Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic optimized fast track concept in general surgery
2005-004814-33Phase 3Completed
- Sponsor
- GWT-TUD
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in colon cancer and liver cancer, sponsored by GWT-TUD. Primary endpoint: recovery of gastrointestinal function. Started Feb 2006; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
colon cancerliver cancer
Beyond the preview
Go deeper on 2005-004814-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004814-33.